Michelle Monje
#44,527
Most Influential Person Now
American neurologist and researcher
Michelle Monje's AcademicInfluence.com Rankings
Michelle Monjemedical Degrees
Medical
#444
World Rank
#610
Historical Rank
#181
USA Rank
Neurology
#82
World Rank
#131
Historical Rank
#27
USA Rank
Download Badge
Medical
Michelle Monje's Degrees
- Bachelors Human Biology Stanford University
Why Is Michelle Monje Influential?
(Suggest an Edit or Addition)According to Wikipedia, Michelle Leigh Monje-Deisseroth is a neuroscientist and neuro-oncologist. She is a professor of neurology at Stanford University and an investigator with the Howard Hughes Medical Institute. She develops new treatments for diffuse intrinsic pontine glioma.
Michelle Monje's Published Works
Number of citations in a given year to any of this author's works
Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author
Published Works
- Inflammatory Blockade Restores Adult Hippocampal Neurogenesis (2003) (2274)
- Irradiation induces neural precursor-cell dysfunction (2002) (1163)
- An Integrative Model of Cellular States, Plasticity, and Genetics for Glioblastoma (2019) (1007)
- Neuronal Activity Promotes Oligodendrogenesis and Adaptive Myelination in the Mammalian Brain (2014) (982)
- Single-cell RNA-seq supports a developmental hierarchy in human oligodendroglioma (2016) (731)
- Extreme sensitivity of adult neurogenesis to low doses of X-irradiation. (2003) (676)
- Excitation-Neurogenesis Coupling in Adult Neural Stem/Progenitor Cells (2004) (649)
- Decoupling genetics, lineages, and microenvironment in IDH-mutant gliomas by single-cell RNA-seq (2017) (612)
- Integrated Molecular Meta-Analysis of 1,000 Pediatric High-Grade and Diffuse Intrinsic Pontine Glioma (2017) (586)
- Reduced H3K27me3 and DNA hypomethylation are major drivers of gene expression in K27M mutant pediatric high-grade gliomas. (2013) (575)
- Electrical and synaptic integration of glioma into neural circuits (2019) (491)
- Functionally-defined Therapeutic Targets in Diffuse Intrinsic Pontine Glioma (2015) (474)
- Neuronal Activity Promotes Glioma Growth through Neuroligin-3 Secretion (2015) (437)
- Recurrent activating ACVR1 mutations in diffuse intrinsic pontine glioma (2014) (410)
- Radiation injury and neurogenesis (2003) (372)
- Developmental and oncogenic programs in H3K27M gliomas dissected by single-cell RNA-seq (2018) (368)
- c-Jun overexpression in CAR T cells induces exhaustion resistance (2019) (348)
- Clinical patterns and biological correlates of cognitive dysfunction associated with cancer therapy. (2008) (306)
- Impaired human hippocampal neurogenesis after treatment for central nervous system malignancies (2007) (275)
- Potent antitumor efficacy of anti-GD2 CAR T-cells in H3K27M+ diffuse midline gliomas (2018) (273)
- CAR T Cells Targeting B7-H3, a Pan-Cancer Antigen, Demonstrate Potent Preclinical Activity Against Pediatric Solid Tumors and Brain Tumors (2019) (264)
- Targeting neuronal activity-regulated neuroligin-3 dependency in high-grade glioma (2017) (257)
- Epigenetic targeting of Hedgehog pathway transcriptional output through BET bromodomain inhibition (2014) (256)
- Pediatric high-grade glioma: biologically and clinically in need of new thinking (2016) (253)
- Hedgehog-responsive candidate cell of origin for diffuse intrinsic pontine glioma (2011) (248)
- Disrupting the CD47-SIRPα anti-phagocytic axis by a humanized anti-CD47 antibody is an efficacious treatment for malignant pediatric brain tumors (2017) (243)
- Transcriptional Dependencies in Diffuse Intrinsic Pontine Glioma. (2017) (234)
- Disruption of Oligodendrogenesis Impairs Memory Consolidation in Adult Mice (2019) (197)
- Cognitive side effects of cancer therapy demonstrate a functional role for adult neurogenesis (2012) (191)
- Methotrexate Chemotherapy Induces Persistent Tri-glial Dysregulation that Underlies Chemotherapy-Related Cognitive Impairment (2019) (182)
- Wrapped to Adapt: Experience-Dependent Myelination (2017) (149)
- GD2-CAR T cell therapy for H3K27M-mutated diffuse midline gliomas (2022) (141)
- Roadmap for the Emerging Field of Cancer Neuroscience (2020) (136)
- Neural Precursor-Derived Pleiotrophin Mediates Subventricular Zone Invasion by Glioma (2017) (134)
- Loss of Adaptive Myelination Contributes to Methotrexate Chemotherapy-Related Cognitive Impairment (2019) (130)
- Locoregionally administered B7-H3-targeted CAR T cells for treatment of atypical teratoid/rhabdoid tumors (2020) (126)
- Myelin Plasticity and Nervous System Function. (2018) (119)
- Functional diversity and co-operativity between subclonal populations of paediatric glioblastoma and diffuse intrinsic pontine glioma cells (2018) (115)
- Cranial radiation therapy and damage to hippocampal neurogenesis. (2008) (101)
- Microglia states and nomenclature: A field at its crossroads (2022) (99)
- Myelin plasticity in the central nervous system (2016) (96)
- Histone Variant and Cell Context Determine H3K27M Reprogramming of the Enhancer Landscape and Oncogenic State. (2019) (90)
- Therapeutic strategies for diffuse midline glioma from high-throughput combination drug screening (2019) (89)
- Non-inflammatory tumor microenvironment of diffuse intrinsic pontine glioma (2018) (86)
- Developmental origins and emerging therapeutic opportunities for childhood cancer (2019) (84)
- Mild respiratory COVID can cause multi-lineage neural cell and myelin dysregulation (2022) (79)
- The oncolytic virus Delta-24-RGD elicits an antitumor effect in pediatric glioma and DIPG mouse models (2019) (75)
- Erratum: Functionally defined therapeutic targets in diffuse intrinsic pontine glioma (2015) (70)
- Contemporary survival endpoints: an International Diffuse Intrinsic Pontine Glioma Registry study. (2016) (68)
- Diffusion-weighted MRI derived apparent diffusion coefficient identifies prognostically distinct subgroups of pediatric diffuse intrinsic pontine glioma (2014) (67)
- Diffuse Intrinsic Pontine Glioma: New Pathophysiological Insights and Emerging Therapeutic Targets (2016) (67)
- Subventricular spread of diffuse intrinsic pontine glioma (2014) (66)
- Human pontine glioma cells can induce murine tumors (2014) (61)
- Neuronal Activity in Ontogeny and Oncology. (2017) (58)
- Bad wrap: Myelin and myelin plasticity in health and disease (2018) (58)
- CRISPRi-based radiation modifier screen identifies long non-coding RNA therapeutic targets in glioma (2019) (56)
- Functional and structural differences in the hippocampus associated with memory deficits in adult survivors of acute lymphoblastic leukemia (2013) (56)
- NF1 mutation drives neuronal activity-dependent initiation of optic glioma (2021) (52)
- Expression of epidermal growth factor variant III (EGFRvIII) in pediatric diffuse intrinsic pontine gliomas (2012) (51)
- Mild respiratory SARS-CoV-2 infection can cause multi-lineage cellular dysregulation and myelin loss in the brain (2022) (50)
- Anti-GD2 synergizes with CD47 blockade to mediate tumor eradication (2022) (47)
- Diffuse Intrinsic Pontine Glioma: From Diagnosis to Next-Generation Clinical Trials (2019) (46)
- An active role for neurons in glioma progression: making sense of Scherer’s structures (2018) (40)
- A Protocol for Rapid Post-mortem Cell Culture of Diffuse Intrinsic Pontine Glioma (DIPG) (2017) (40)
- Effect of cancer therapy on neural stem cells: implications for cognitive function (2012) (37)
- Diffuse intrinsic pontine glioma: molecular landscape and emerging therapeutic targets. (2019) (36)
- Activity Shapes Neural Circuit Form and Function: A Historical Perspective (2020) (34)
- Neuronal activity in the glioma microenvironment (2017) (34)
- Microglia in Cancer Therapy-Related Cognitive Impairment (2021) (31)
- ALK2 inhibitors display beneficial effects in preclinical models of ACVR1 mutant diffuse intrinsic pontine glioma (2019) (31)
- Pharmacologic inhibition of lysine specific demethylase-1 (LSD1) as a therapeutic and immune-sensitization strategy in pediatric high grade glioma (pHGG). (2020) (29)
- Myelination in the Mammalian Brain Neuronal Activity Promotes Oligodendrogenesis and Adaptive (2014) (29)
- Monosynaptic tracing maps brain-wide afferent oligodendrocyte precursor cell connectivity (2019) (28)
- Senescence Induced by BMI1 Inhibition Is a Therapeutic Vulnerability in H3K27M-Mutant DIPG (2020) (27)
- International experience in the development of patient-derived xenograft models of diffuse intrinsic pontine glioma (2018) (27)
- Free radicals are involved in the damage to protein synthesis after anoxia/aglycemia and NMDA exposure (2000) (26)
- Neurological complications following treatment of children with brain tumors. (2011) (25)
- ALK2 inhibitors display beneficial effects in preclinical models of ACVR1 mutant diffuse intrinsic pontine glioma (2019) (23)
- The neurobiology of long COVID (2022) (23)
- Emerging mechanistic underpinnings and therapeutic targets for chemotherapy-related cognitive impairment. (2019) (22)
- The international diffuse intrinsic pontine glioma registry: an infrastructure to accelerate collaborative research for an orphan disease (2017) (21)
- Brain Perfusion and Diffusion Abnormalities in Children Treated for Posterior Fossa Brain Tumors (2017) (21)
- Calbindin overexpression buffers hippocampal cultures from the energetic impairments caused by glutamate (2001) (21)
- Defining Microglial States and Nomenclature: A Roadmap to 2030 (2022) (20)
- Settling a Nervous Stomach: The Neural Regulation of Enteric Cancer. (2017) (20)
- Maladaptive myelination promotes generalized epilepsy progression (2022) (17)
- Patient-derived models recapitulate heterogeneity of molecular signatures and drug response in pediatric high-grade glioma (2021) (17)
- CD58 Aberrations Limit Durable Responses to CD19 CAR in Large B Cell Lymphoma Patients Treated with Axicabtagene Ciloleucel but Can be Overcome through Novel CAR Engineering (2020) (17)
- Hedgehogs, flies, Wnts and MYCs: the time has come for many things in medulloblastoma. (2011) (17)
- MRI-based radiomics for prognosis of pediatric diffuse intrinsic pontine glioma: an international study (2021) (16)
- Glioblastoma remodeling of neural circuits in the human brain decreases survival (2021) (13)
- TERT and DNMT1 expression predict sensitivity to decitabine in gliomas. (2020) (13)
- Gene therapy effectiveness differs for neuronal survival and behavioral performance (2001) (13)
- Synaptic Communication in Brain Cancer (2020) (13)
- DIPG-22. A PHASE 1 TRIAL OF THE HISTONE DEACETYLASE INHIBITOR PANOBINOSTAT IN PEDIATRIC PATIENTS WITH RECURRENT OR REFRACTORY DIFFUSE INTRINSIC PONTINE GLIOMA: A PEDIATRIC BRAIN TUMOR CONSORTIUM (PBTC) STUDY (2018) (12)
- Durable response of a radiation-induced, high-grade cerebellar glioma to temozolomide (2007) (12)
- Neuronal hyperexcitability drives central and peripheral nervous system tumor progression in models of neurofibromatosis-1 (2022) (10)
- Potent antitumor efficacy of anti-GD2 CAR T cells in H3-K27M+ diffuse midline gliomas (2018) (10)
- BAF Complex Maintains Glioma Stem Cells in Pediatric H3K27M Glioma (2022) (9)
- The landscape of tumor cell states and spatial organization in H3-K27M mutant diffuse midline glioma across age and location (2022) (9)
- The Neural Regulation of Cancer (2020) (9)
- Partitioned glioma heritability shows subtype-specific enrichment in immune cells. (2021) (8)
- Functional diversity and cooperativity between subclonal populations of pediatric glioblastoma and diffuse intrinsic pontine glioma cells (2018) (7)
- Microenvironmental interactions of oligodendroglial cells. (2021) (7)
- The bright and the dark side of myelin plasticity: Neuron-glial interactions in health and disease. (2020) (7)
- GD2-CAR T cell therapy for H3K27M-mutated diffuse midline gliomas (2022) (7)
- Open questions: why are babies rarely born with cancer? (2018) (7)
- Glioma synapses recruit mechanisms of adaptive plasticity (2021) (6)
- A comparative study of brain tumor cells from different age and anatomical locations using 3D biomimetic hydrogels. (2020) (6)
- Abstract CT031: GD2 CAR T cells mediate clinical activity and manageable toxicity in children and young adults with DIPG and H3K27M-mutated diffuse midline gliomas (2021) (6)
- Understanding the Deadly Silence of Posterior Fossa A Ependymoma. (2020) (5)
- NCI-CONNECT: Comprehensive Oncology Network Evaluating Rare CNS Tumors-Histone Mutated Midline Glioma Workshop Proceedings. (2020) (5)
- Complete Ocular Paresis in a Child with Posterior Fossa Syndrome (2012) (5)
- EPCT-14. GD2 CAR T-CELLS MEDIATE CLINICAL ACTIVITY AND MANAGEABLE TOXICITY IN CHILDREN AND YOUNG ADULTS WITH H3K27M-MUTATED DIPG AND SPINAL CORD DMG (2021) (5)
- Transition to a mesenchymal state in neuroblastoma confers resistance to anti-GD2 antibody via reduced expression of ST8SIA1 (2022) (5)
- Chemoradiation impairs normal developmental cortical thinning in medulloblastoma (2017) (5)
- H3-K27M-mutant nucleosomes interact with MLL1 to shape the glioma epigenetic landscape. (2022) (4)
- Spinal Cord Injury - Healing from Within. (2021) (4)
- Neural Signaling in Cancer. (2022) (4)
- Unravelling the Mechanisms of Cancer-Related Cognitive Dysfunction in Non-Central Nervous System Cancer. (2021) (4)
- Correction to: International experience in the development of patient-derived xenograft models of diffuse intrinsic pontine glioma (2018) (4)
- Maladaptive myelination promotes epileptogenesis in absence epilepsy (2020) (4)
- Drug screening linked to molecular profiling identifies novel dependencies in patient-derived primary cultures of paediatric high grade glioma and DIPG (2018) (4)
- Abstract 3271: Novel orthotopic pediatric high grade glioma xenografts evaluated with magnetic resonance imaging mimic human disease (2015) (4)
- DIPG-10. A Phase I trial of panobinostat following radiation therapy in children with diffuse intrinsic pontine glioma (DIPG) or H3K27M-mutated thalamic diffuse midline glioma (DMG): Report from the Pediatric Brain Tumor Consortium (PBTC-047) (2022) (3)
- DIFFUSE INTRINSIC PONTINE GLIOMA (DIPG) (2012) (3)
- GABAergic neuron-to-glioma synapses in diffuse midline gliomas (2022) (3)
- OMIC-11. SINGLE CELL RNA SEQUENCING FROM THE CSF OF SUBJECTS WITH H3K27M+ DIPG/DMG TREATED WITH GD2 CAR T-CELLULAR THERAPY (2021) (3)
- H3-K27M-Mutant Nucleosomes Interact with MLL1 to Shape the Glioma Epigenetic Landscape (2021) (3)
- Neurological complications in adults. (2009) (3)
- Inhibiting USP16 rescues stem cell aging and memory in an Alzheimer’s model (2020) (2)
- BT-02FUNCTIONALLY-DEFINED THERAPEUTIC TARGETS IN DIFFUSE INTRINSIC PONTINE GLIOMA. (2015) (2)
- DIPG-03. TARGETING PI3K USING THE BLOOD BRAIN BARRIER PENETRABLE INHIBITOR, GDC-0084, FOR THE TREATMENT OF DIFFUSE INTRINSIC PONTINE GLIOMA (DIPG) (2019) (2)
- Treating cancer therapy–related cognitive impairment (2020) (2)
- Targeting neuronal activity-regulated neuroligin-3 dependency for high-grade glioma therapy (2017) (2)
- Neuron–Glial Interactions in Health and Brain Cancer (2022) (2)
- CELL BIOLOGY AND SIGNALING (2010) (2)
- EXPERIMENTAL THERAPEUTICS AND PHARMACOLOGY (2013) (2)
- Bespoke myelin tailored to neuron type (2020) (2)
- QUALITY OF LIFE/AFTERCARE (2012) (2)
- CHAPTER 15 – Neurological Complications of Oncological Therapy (2008) (2)
- IMMU-19. LSD1 MODULATES NK CELL IMMUNOTHERAPY THROUGH AN ONCO-IMMUNOGENIC GENE SIGNATURE IN DIPG (2018) (2)
- Invasive glioma cells: The malignant pioneers that follow the current (2022) (1)
- DIPG-29. PHOSPHATIDYLINOSITOL-4,5-BISPHOSPHATE 3-KINASE (PI3K) INHIBITION DRIVES PROTEIN KINASE C ACTIVATION (PKC) IN DIFFUSE INTRINSIC PONTINE GLIOMA (DIPG) (2020) (1)
- DIPG-21. ELECTRICAL INTEGRATION OF GLIOMA INTO NEURAL CIRCUITRY (2019) (1)
- ME-08NEURONS PROMOTE GLIOMA GROWTH IN AN ACTIVITY-DEPENDENT MANNER (2014) (1)
- LGG-01. NF1 MUTATION DRIVES NEURONAL ACTIVITY-DEPENDENT OPTIC GLIOMA INITIATION (2021) (1)
- Patient-Derived Orthotopic Xenografts and Cell Lines from Pediatric High-Grade Glioma Recapitulate the Heterogeneity of Histopathology, Molecular Signatures, and Drug Response (2020) (1)
- Abstract CT001: Major tumor regressions in H3K27M-mutated diffuse midline glioma (DMG) following sequential intravenous (IV) and intracerebroventricular (ICV) delivery of GD2-CAR T cells (2022) (1)
- Neuronal-Activity Dependent Mechanisms of Small Cell Lung Cancer Progression (2023) (1)
- Kinase-Modulated Bioluminescent Indicators Enable Noninvasive Imaging of Drug Activity in the Brain (2023) (1)
- Myelin plasticity in ventral tegmental area is required for opioid reward (2022) (1)
- HG-78SYNTHETIC LETHAL EPIGENETIC INTERACTIONS IN K27M MUTATED DIPG (2016) (1)
- HGG-22. TARGETING NEURONAL ACTIVITY-REGULATED NEUROLIGIN-3 DEPENDENCY FOR HIGH-GRADE GLIOMA THERAPY (2017) (1)
- DIPG-29. GENOMIC LANDSCAPE OF DIFFUSE INTRINSIC PONTINE GLIOMA: AN ANALYSIS OF THE DIPG-BATS COHORT (2017) (1)
- BSTM-04. NEURONAL-ACTIVITY SECRETED BDNF INCREASES DIPG PROLIFERATION. (2019) (1)
- DIPG-41. IDENTIFICATION OF BIRC5 AS A NOVEL THERAPEUTIC TARGET FOR DIFFUSE INTRINSIC PONTINE GLIOMA (2018) (1)
- HG-04NEURONAL ACTIVITY-REGULATED SECRETION OF NEUROLIGIN-3 PROMOTES GLIOMA GROWTH (2015) (1)
- The oncolytic virus Delta-24-RGD elicits an antitumor effect in pediatric glioma and DIPG mouse models (2019) (1)
- Glioblastoma remodelling of human neural circuits decreases survival. (2023) (1)
- Generation and multi-dimensional profiling of a childhood cancer cell line atlas defines new therapeutic opportunities. (2023) (0)
- Developmental origins and emerging therapeutic opportunities for childhood cancer (2019) (0)
- Open questions: why are babies rarely born with cancer? (2018) (0)
- Cancer hallmarks intersect with neuroscience in the tumor microenvironment. (2023) (0)
- c-Jun overexpression in CAR T cells induces exhaustion resistance (2019) (0)
- Mini-review: Aplastic myelin following chemotherapy (2022) (0)
- Neurologic Complications of Oncologic Therapy (2016) (0)
- PP171-SUN INTRADIALYTIC PARENTERAL NUTRITION IN CHRONIC HEMODIALYSIS PATIENTS (2012) (0)
- Glioma-Neuronal Interactions (2020) (0)
- Inflaming glioma growth (2019) (0)
- TMIC-09. EXCITATORY SYNAPSES BETWEEN PRESYNAPTIC NEURONS AND POSTSYNAPTIC GLIOMA CELLS PROMOTE GLIOMA PROGRESSION (2018) (0)
- BDNF is necessary for neuronal activity-regulated oligodendrogenesis (P2.409) (2018) (0)
- EPID-12PSYCHIATRIC SYMPTOMS IN CHILDREN WITH CRANIOPHARYNGIOMA (2015) (0)
- Adaptive and maladaptive myelination in health and disease (2022) (0)
- HG-23BET INHIBITORS WORK SYNERGISTICALLY WITH PANOBINOSTAT IN TREATING DIFFUSE INTRINSIC PONTINE GLIOMA. (2016) (0)
- INSP-03. Neuronal regulation of glioma progression (2022) (0)
- ME-04SUBVENTRICULAR SPREAD OF DIFFUSE INTRINSIC PONTINE GLIOMA (2014) (0)
- DIPG-25. Patterns of cerebrospinal fluid diversion and survival in children with diffuse intrinsic pontine glioma: a report from the International Diffuse Intrinsic Pontine Glioma Registry (2022) (0)
- Long-Term Cognitive and Neuropsychiatric Outcomes in Adults Who Have Received Chimeric Antigen Receptor T-Cell (CAR-T) Therapy for Aggressive Lymphoma at Stanford - a Pilot Feasibility Study (2022) (0)
- DIPG-38. Significant tumor regression of H3K27M-mutated diffuse midline glioma of the brainstem with panobinostat: a case report. (2022) (0)
- Complications of radiation and chemotherapy Radiation therapy Acute reactions Cerebral edema Headaches Nausea Encephalopathy Early – delayed reactions Encephalopathy Cognitive dysfunction Myelopathy Endocrine dysfunction Vasculopathy Late – delayed reactions Cognitive dysfunction Dementia Necrosis L (2008) (0)
- Neuronal activity-regulated secretion of neuroligin-3 promotes glioma growth (S43.003) (2015) (0)
- DDDR-25. CO-INHIBITION OF KINASE SIGNALING PATHWAYS AND EPIGENETIC REGULATORS OVERCOMES COMPENSATORY EFFECTS IN PEDIATRIC HIGH-GRADE GLIOMAS (2022) (0)
- Differential Sensitivity of Oligodendrocyte Precursor Cells and Microglia to Methotrexate in Grey Versus White Matter (P7.011) (2014) (0)
- HIGH GRADE GLIOMAS AND DIPG (2014) (0)
- Abstract 959: Targeting neuronal activity regulated neuroligin-3 dependency for high-grade glioma therapy (2017) (0)
- EOLP-04. A CALL TO ACTION TO INCREASE ACCESS TO POST-MORTEM BRAIN TUMOR DONATIONS: GIFT FROM A CHILD (2022) (0)
- CRISPRi-based radiation modifier screen identifies long non-coding RNA therapeutic targets in glioma (2020) (0)
- Abstract PR04: GD2-directed chimeric antigen receptor T cells mediate potent antitumor effect and cure in xenograft models of diffuse intrinsic pontine glioma (2018) (0)
- TMOD-13. RESEARCH RESOURCES FOR OLIGODENDROGLIOMA NOW AVAILABLE TO RESEARCH COMMUNITY (2020) (0)
- Abstract PO027: Glioma cells within high functional connectivity network hubs exhibit a proliferative and infiltrative tumor phenotype (2021) (0)
- CBIO-48DECODING THE CELLULAR HETEROGENEITY OF MALIGNANT GLIOMA (2015) (0)
- EPCO-21. THE SPATIAL ORGANIZATION OF H3-K27M MUTANT DIFFUSE MIDLINE GLIOMA (2022) (0)
- Abstract LB-036: Neuronal activity-regulated secretion of neuroligin-3 promotes glioma growth (2015) (0)
- Neuronal hyperexcitability drives central and peripheral nervous system tumor progression in models of neurofibromatosis-1 (2022) (0)
- MODL-17. The Childhood Brain Cancer Cell Line Atlas: A Resource for Biomarker Identification and Therapeutic Development (2022) (0)
- IMG-10. MRI-BASED RADIOMIC PROGNOSTIC MARKERS OF DIFFUSE MIDLINE GLIOMA (2020) (0)
- Abstract 958: Anti-GD2 chimeric antigen receptor T cells as a potent immunotherapy regimen in xenograft models of histone 3 K27M mutant diffuse midline glioma (2018) (0)
- TMIC-18. ELECTRICAL CIRCUIT INTEGRATION OF GLIOMA THROUGH NEURON-GLIOMA SYNAPSES AND POTASSIUM CURRENTS (2019) (0)
- HG-99A PATIENT-DERIVED PAEDIATRIC HIGH GRADE GLIOMA AND DIPG CELL CULTURE PANEL RECAPITULATING THE GENOTYPIC AND PHENOTYPIC DIVERSITY OF THE DISEASE (2016) (0)
- DIPG-32. AKT SIGNALING DRIVES RESISTANCE TO ONC201 IN DIFFUSE INTRINSIC PONTINE GLIOMA (DIPG) (2020) (0)
- A light-gated transcriptional recorder for detecting cell-cell contacts (2022) (0)
- Decision letter: Rescue of cognitive function following fractionated brain irradiation in a novel preclinical glioma model (2018) (0)
- EXTH-42. COMBINATION OF MAPK PATHWAY INHIBITORS AND IMMUNE CHECKPOINT BLOCKADE IN BRAF-MUTANT HIGH-GRADE GLIOMA (2021) (0)
- DIPG-55. PATTERNS OF CEREBROSPINAL FLUID DIVERSION AND SURVIVAL IN CHILDREN WITH DIFFUSE INTRINSIC PONTINE GLIOMA: A REPORT FROM THE INTERNATIONAL DIPG REGISTRY (2020) (0)
- EPCO-26. PROJECT HOPE: “PEDIATRIC AND AYA HIGH-GRADE GLIOMA OMICS PROJECT”- A LONGITUDINAL MOLECULAR LANDSCAPE OF HIGH-GRADE GLIOMAS RESOLVED AT SINGLE-CELL LEVEL (2020) (0)
- DIPG-69. CHARACTERISTICS OF PATIENTS ≥ 10 YEARS OF AGE WITH DIFFUSE INTRINSIC PONTINE GLIOMA: A REPORT FROM THE INTERNATIONAL DIPG REGISTRY (2018) (0)
- STMC-01. OLIGODENDROCYTE PRECURSOR CELL HYPERCELLULARITY IN A MOUSE MODEL OF NEUROFIBROMATOSIS TYPE (NF1) RESEMBLES PRENEOPLASTIC LESIONS (2017) (0)
- Neural Precursor Cell-Derived Pleiotrophin Mediates Glioma Invasion of the Subventricular Zone (2018) (0)
- DIPG-22. IDENTIFICATION OF THERAPEUTIC TARGETS IN DIPGS USING LARGE-SCALE RNAI SCREENING (2017) (0)
- HG-97PAEDIATRIC GBM AND DIPG SUBCLONES CO-OPERATE TO PROMOTE TUMORIGENESIS. (2016) (0)
- HGG-02. NEUROPHYSIOLOGICAL SMALL MOLECULE SCREEN TO TARGET NEURON-GLIOMA INTERACTIONS IN PEDIATRIC HIGH-GRADE GLIOMAS (2021) (0)
- Non-inflammatory tumor microenvironment of diffuse intrinsic pontine glioma (2018) (0)
- EXTH-67. PHARMACOLOGIC INHIBITION OF LYSINE SPECIFIC DEMETHYLASE-1 (LSD1) AS AN ADJUVANT IMMUNE-SENSITIZATION STRATEGY IN DIFFUSE INTRINSIC PONTINE GLIOMA (DIPG) (2020) (0)
- TBIO-06. BDNF-TRKB SIGNALING REGULATES NEURON-GLIOMA SYNAPTOGENESIS AND PROMOTES TUMOR PROGRESSION (2020) (0)
- Cancer Cell Integrated molecular meta-analysis of 1000 paediatric high grade and diffuse intrinsic pontine glioma (2017) (0)
- DIPG-55. TARGETING SENESCENT CELLS WITH ABT-263 ENHANCES CELL DEATH INDUCED BY BMI1 INHIBITION AND IONIZING RADIATION IN DIPG (2018) (0)
- EXTH-37. TARGETING EPIGENETIC VULNERABILITIES IDENTIFIED FROM A CRISPR SCREEN IN H3.3K27M DIPG (2020) (0)
- DIPG-03. EXCITATORY SYNAPSES BETWEEN PRESYNAPTIC NEURONS AND POSTSYNAPTIC GLIOMA CELLS PROMOTE DIPG PROGRESSION (2018) (0)
- ATRT-09. IDENTIFICATION OF POTENTIAL GENETIC DRIVERS OF METHOTREXATE (MTX) RESISTANCE IN ATYPICAL TERATOID RHABDOID TUMOURS (ATRT) THROUGH A GENOME-WIDE RNAI SCREEN BIOL-03. PROTEIN TRANSLATION FROM NON-CODING GENOMIC LOCI PRODUCE BIOLOGICALLY-ACTIVE PROTEINS IMPLICATED IN CANCER CELL SURVIVAL IN PE (2021) (0)
- TAMI-21. MALIGNANT GLIOMAS REMODEL FUNCTIONAL NEURAL CIRCUITS THROUGH PARACRINE SIGNALING WHICH CONFERS A NEGATIVE PROGNOSIS (2020) (0)
- Neuronal Activity Promotes Oligodendrogliogenesis and Myelination in the Mammalian Brain (S42.004) (2014) (0)
- Abstract PL05-03: Histone-3K27M mutant diffuse midline gliomas of childhood: Epigenetic pathogenesis and therapeutic opportunities (2018) (0)
- IM-04DELTA-24-RDG AS AN ALTERNATIVE THERAPEUTIC TOOL FOR pHGG/DIPG (2015) (0)
- HGG-06. EARLY GABAERGIC NEURONAL LINEAGE DEFINES DEPENDENCIES IN HISTONE H3 G34R/V GLIOMA (2021) (0)
- DIPG-11. NEURAL PRECURSOR CELL:GLIOMA INTERACTIONS MEDIATE TUMOR COLONIZATION OF THE SUBVENTRICULAR ZONE BY DIPG. (2017) (0)
- CNSC-17. GLIOMA SYNAPSES RECRUIT MECHANISMS OF ADAPTIVE PLASTICITY (2022) (0)
- TAMI-69. NF1 MUTATION DRIVES NEURONAL ACTIVITY-DEPENDENT OPTIC GLIOMA INITIATION (2021) (0)
- Tumor inflammation-associated neurotoxicity (2023) (0)
- EPCO-06. AGE- AND REGION-SPECIFIC MULTI-OMIC CHARACTERIZATION OF H3-K27M MUTANT DIFFUSE MIDLINE GLIOMA (2021) (0)
- GENT-16. REDEFINING THE CELLULAR ARCHITECTURE OF ADULT AND PEDIATRIC GLIOBLASTOMAS THROUGH LARGE-SCALE SINGLE-CELL ANALYSES (2016) (0)
- HGG-04. TARGETING GABAERGIC NEURON-GLIOMA SYNAPSES IN DIFFUSE INTRINSIC PONTINE GLIOMA (DIPG) THROUGH ANTI-EPILEPTIC DRUG REPURPOSING (2021) (0)
- Abstract PR003: Lineage plasticity dictates responsiveness to anti-GD2 therapy in neuroblastoma (2022) (0)
- HG-73SAFETY AND FEASIBILITY OF A MULTI-INSTITUTIONAL PHASE II TRIAL INCOPORATING BIOPSY AND MOLECULARLY DETERMINED TREATMENT OF CHILDREN AND YOUNG ADULTS WITH NEWLY DIAGNOSED DIFFUSE INTRINSIC PONTINE GLIOMAS (DIPG). (2016) (0)
- HG-110SINGLE-CELL TRANSCRIPTOME ANALYSIS IN PEDIATRIC HEMISPHERIC AND MIDLINE HIGH-GRADE GLIOMAS. (2016) (0)
- Locoregionally administered B7-H3-targeted CAR T cells for treatment of atypical teratoid/rhabdoid tumors (2020) (0)
- BT-05FUNCTIONAL DIVERSITY AND CO-OPERATIVITY OF SUBCLONAL POPULATIONS OF PAEDIATRIC GLIOBLASTOMA AND DIFFUSE INTRINSIC PONTINE GLIOMA CELLS (2015) (0)
- Pediatric Brain Tumors. (2020) (0)
- CNSC-07. MECHANISMS OF GLIOBLASTOMA-INDUCED CORTICAL REMODELING IDENTIFY THERAPEUTIC VULNERABILITIES (2022) (0)
- Recurrent activating ACVR1/ALK2 mutations in diffuse intrinsic pontine glioma (2014) (0)
- Cancer neuroscience: State of the field, emerging directions (2023) (0)
- PDTM-21. MULTI-MODAL PROFILING OF PEDIATRIC HIGH-GRADE GLIOMA SINGLE CELLS USING PATCH-SEQ (2019) (0)
- HG-16CDK7 INHIBITION IN DIFFUSE INTRINSIC PONTINE GLIOMA (2016) (0)
- TAMI-28. IDENTIFICATION OF A NEUROLIGIN-3 BINDING PARTNER IN HIGH-GRADE GLIOMAS AND NORMAL PROGENITORS (2021) (0)
- Abstract 959: Immune signatures of GD2 CAR T cell activity in H3K27M+ diffuse midline glioma patients (2023) (0)
- Tri-glial dysregulation in methotrexate chemotherapy-induced cognitive impairment (2018) (0)
- Abstract IA20: Neuronal activity promotes proliferation of normal and neoplastic glial cells (2020) (0)
- Multifocal demyelinating leukoencephalopathy and oligodendroglial lineage cell loss with immune effector cell-associated neurotoxicity syndrome (ICANS) following CD19 CAR T-cell therapy for mantle cell lymphoma. (2023) (0)
- Title: CAR T cells targeting B7-H3, a Pan-Cancer Antigen, Demonstrate Potent Preclinical Activity Against Pediatric Solid Tumors and Brain Tumors (2018) (0)
- GC-21PSYCHIATRIC SYMPTOMS IN CHILDREN WITH SUPRASELLAR TUMORS (2016) (0)
- HGG-20. NEURONAL ACTIVITY PROMOTES PEDIATRIC GLIOMA INVASION (2017) (0)
- THE TREATMENT FOR HISTOLOGICALLY UNCONFIRMED INTRACRANIAL GERM CELL TUMORS : EXPERIENCE OF 38 CASES (2012) (0)
- DIPG-36. ANTI-GD2 CHIMERIC ANTIGEN RECEPTOR T CELLS AS A POTENT IMMUNOTHERAPY REGIMEN IN XENOGRAFT MODELS OF HISTONE 3 K27M MUTANT DIFFUSE MIDLINE GLIOMA (2018) (0)
- Clinically relevant concurrent BRAF and MEK inhibition alters differentiation states and sensitizes BRAF V600E-mutated high-grade gliomas to immune checkpoint blockade (2023) (0)
- PTPS-24MECHANISMS OF DIFFUSE INTRINSIC PONTINE GLIOMA METASTASIS TO THE SUBVENTRICULAR ZONE (2015) (0)
- Pharmacologic inhibition of lysine specific demethylase-1 (LSD1) as a therapeutic and immune-sensitization strategy in diffuse intrinsic pontine glioma (DIPG) (2019) (0)
- Targeting neuronal activity-regulated neuroligin-3 secretion for glioma therapy (CCI.001) (2017) (0)
- Neural Stem Cells and the Effects of Cancer Therapy (2015) (0)
- IMMU-55. GD2 IS A MACROPHAGE CHECKPOINT MOLECULE AND COMBINED GD2/CD47 BLOCKADE RESULTS IN SYNERGISTIC EFFECTS AGAINST GD2 POSITIVE MALIGNANCIES (2020) (0)
- Remote neuronal activity drives glioma infiltration via Sema4f (2023) (0)
- HGG-53. PROJECT HOPE: “PEDIATRIC AND AYA HIGH-GRADE GLIOMA OMICS PROJECT”- A LONGITUDINAL MOLECULAR LANDSCAPE OF HIGH-GRADE GLIOMAS RESOLVED AT SINGLE-CELL LEVEL (2020) (0)
- CBIO-20. HIGH LEVELS OF TERT CONFER SENSITIVITY TO THE DNA HYPOMETHYLATING AGENT DECITABINE (DAC) IN GLIOMAS (2021) (0)
- TMIC-46. GLIOMA-INDUCED SYNAPTOGENESIS IS ENRICHED WITHIN FUNCTIONAL CONNECTIVITY NETWORK HUBS AND INFLUENCES LANGUAGE PROCESSING IN ADULT IDH WT GLIOBLASTOMA (2019) (0)
- HGG-05. NEURONAL ACTIVITY PROMOTES PEDIATRIC HIGH-GRADE GLIOMA GROWTH THROUGH A NLGN3-CSPG4 SIGNALING AXIS (2021) (0)
- THER-31. TARGETING THE HISTONE DEMETHYLASE LSD1 FOR SELECTIVE APOPTOSIS AND IMMUNE-SENSITIZATION IN PEDIATRIC DIPG (2019) (0)
- BIOL-05. MAPK PATHWAY INHIBITION SENSITIZES TO IMMUNOTHERAPY IN BRAF-MUTANT GLIOMAS (2021) (0)
- HG-72DIPG CELLS ESCAPE THE PONS EARLY DURING TUMOUR EVOLUTION (2016) (0)
- Electrical and synaptic integration of glioma into neural circuits (2019) (0)
- Comment on "Genetic and genomic alterations differentially dictate low-grade glioma growth through cancer stem cell-specific chemokine recruitment of T cells and microglia", Guo et al. 2019, Neuro-Oncology. (2019) (0)
- Novel Treatment Combinations with Panobinostat in Diffuse Intrinsic Pontine Glioma (P3.278) (2016) (0)
- DIPG-52. ACTIVE CHROMATIN IN H3K27M DIPG REVEALS DISTINCT EPIGENETIC SUBTYPES AND SUBTYPE-SPECIFIC MECHANISMS OF PATHOGENESIS (2018) (0)
- DIPG-15. Major tumor regressions in H3K27M-mutated diffuse midline glioma (DMG) following sequential intravenous (IV) and intracerebroventricular (ICV) delivery of GD2-CAR T-cells (2022) (0)
- HGG-21. MALIGNANT SYNAPTIC PLASTICITY IN PEDIATRIC HIGH-GRADE GLIOMAS (2021) (0)
- PM-04DECODING THE CELLULAR HETEROGENEITY OF PEDIATRIC HIGH GRADE GLIOMA (2015) (0)
This paper list is powered by the following services:
Other Resources About Michelle Monje
What Schools Are Affiliated With Michelle Monje?
Michelle Monje is affiliated with the following schools:
